SubjectWell, an engagement platform for matching patients with chronic health conditions to new care options, announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient recruitment efforts, expand its support of cancer research, and fund production of its awareness initiatives for post-approval treatments. Read more.
SubjectWell’s B Round Nets $35M
